Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W H Frishman

Showing results (41-50 of 311) with videos related to

Pageof 32
Sort By:
Circulation|June 1, 1983
Multifactorial actions of beta-adrenergic blocking drugs in ischemic heart disease: current conceptsW H Frishman
Heart Disease (Hagerstown, Md.)|April 27, 2002
Student research projects and theses: should they be a requirement for medical school graduation?W H Frishman
International Journal of Cardiology|January 1, 1982
The beta-adrenoceptor blocking drugsW H Frishman
The American Journal of Cardiology|May 15, 1987
Clinical significance of beta 1-selectivity and intrinsic sympathomimetic activity in a beta-adrenergic blocking drugW H Frishman
American Journal of Nephrology|January 1, 1987
Calcium channel blockers in systemic hypertensionW H Frishman
Journal of Clinical Hypertension|September 1, 1986
Calcium-channel blockers for hypertensive emergenciesW H Frishman
Journal of Clinical Pharmacology|June 1, 1989
New therapeutic modalities in hypertension: focus on a new calcium antagonist-nicardipineW H Frishman
The American Journal of Cardiology|April 9, 1992
Comparative efficacy and concomitant use of bepridil and beta blockers in the management of angina pectorisW H Frishman
The New England Journal of Medicine|December 10, 1998
CarvedilolW H Frishman
The New England Journal of Medicine|April 21, 1983
Drug therapy. Pindolol: a new beta-adrenoceptor antagonist with partial agonist activityW H Frishman
Pageof 32

Showing results (41-50 of 311) with videos related to

Sort By:
Pageof 32
Circulation|June 1, 1983
Multifactorial actions of beta-adrenergic blocking drugs in ischemic heart disease: current conceptsW H Frishman
Heart Disease (Hagerstown, Md.)|April 27, 2002
Student research projects and theses: should they be a requirement for medical school graduation?W H Frishman
International Journal of Cardiology|January 1, 1982
The beta-adrenoceptor blocking drugsW H Frishman
The American Journal of Cardiology|May 15, 1987
Clinical significance of beta 1-selectivity and intrinsic sympathomimetic activity in a beta-adrenergic blocking drugW H Frishman
American Journal of Nephrology|January 1, 1987
Calcium channel blockers in systemic hypertensionW H Frishman
Journal of Clinical Hypertension|September 1, 1986
Calcium-channel blockers for hypertensive emergenciesW H Frishman
Journal of Clinical Pharmacology|June 1, 1989
New therapeutic modalities in hypertension: focus on a new calcium antagonist-nicardipineW H Frishman
The American Journal of Cardiology|April 9, 1992
Comparative efficacy and concomitant use of bepridil and beta blockers in the management of angina pectorisW H Frishman
The New England Journal of Medicine|December 10, 1998
CarvedilolW H Frishman
The New England Journal of Medicine|April 21, 1983
Drug therapy. Pindolol: a new beta-adrenoceptor antagonist with partial agonist activityW H Frishman
Pageof 32